Geron Corporation (GERN) support and resistance · rev $109.3M
Geron Corporation (GERN) is a biotechnology company listed on US.
This page maps Geron Corporation (GERN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
GERN currently screens at market cap $878.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new GERN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the GERN quote page for the session range and the stock page for the full model.
Not investment advice.